SK Chemicals’ joint sales and marketing agreement of SKY Zoster with Daewoong

‘SKY Zoster,’ the first shingles vaccine developed by an Korean pharmaceutical company and become a blockbuster medicinal drug with collective sales of KRW 10 billion this year, will have more active marketing activities in the market.

SK Chemicals(CEO Man-Hoon Park) announced conclusion of a joint marketing and sales agreement of the shingles vaccine ‘SKY Zoster’ with Daewoong Pharmaceutical ...